Your Trusted Source for Life Sciences Data
Discover emerging life science companies, uncover qualified leads, and identify the right partners faster. By combining expert human curation with AI-driven intelligence, our platform delivers the insights you need to accelerate business development, licensing, and investment decisions with confidence.
Unique data sourcing process
leading to an exclusive data set
Over 1,040,000 regularly
updated clinical trials
69,000 companies with over
380,000 management contact details
Over 43,000 Biotech, Pharma and Medtech
assets available for licensing
Investor Database including
direct contact details
License agreements with payment
structures and original contract
BIOTECHGATE DIGITAL PARTNERING
Virtual business development & licensing event
Join five days of digital partnering, workshops and networking sessions. Establish new global connections thanks to pre-arranged one-on-one Zoom meetings.
Solutions by industry
Biotechgate is a versatile information source
catering to the entire life science industry.
What our clients say
Latest industry news
Sectra completes Oxipit acquisition, accelerating autonomous AI in radiology
15 Apr 2026
Read moreWuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing
15 Apr 2026
Read moreHIKMICRO Strengthens Instrumentation Push with LRG10 Series Radar Level Meter
15 Apr 2026
Read moreUpcoming Conferences
16April2026
16April2026
7th Norwegian Life Science Investor Partnering Day
Oslo, NorwayLife science is entering a new phase. Capital is shifting, investor expectations are evolving, and companies must demonstrate not only strong science, but scalable and globally relevant business models. From strategic pharma partnerships to venture capital recalibrating its playbook, the investment landscape is being reset.
For small-market innovators, this raises critical questions: How do you attract international capital? What defines an investable company in today’s market? And how can Nordic strengths in sustainability, digitalisation, advanced therapeutics and AI translate into global impact?
Norway and the Nordics are uniquely positioned to contribute to the next generation of solutions for human and planetary health. But realising this potential requires alignment between founders, investors, and strategic partners.
Hear Nordic and international investors and thought leaders reflect around the Norwegian and Nordic investment landscape, and meet investors and life science companies for 1:1 partnering.
Read more 21April2026
22April2026
Life Science Innovation Northwest 2026
Seattle, USALife Science Innovation Northwest (LSINW) is the can’t-miss gathering for the PNW life science community. Nowhere else will you find CEOs, investors, research institutions, global health leaders, entrepreneurs, and public and private life science organizations connecting at this scale. With high-impact programming, elevated networking, and dedicated time to meet strategic partners, collaborators, and investors, LSINW 2026 is designed to help attendees build meaningful relationships that move ideas and companies forward.
Read more 21April2026
22April2026
German Biotech Days
Leipzig, GermanyGermany's largest biotech event, the German Biotech Days 2026 (Deutsche Biotechnologietage, DBT), will take place on April 21 and 22 in Leipzig. The event is the national forum for the German biotechnology industry. The DBT brings together entrepreneurs with scientists and partners from politics, funding institutions and administration. The two-day program highlights the diverse fields of application and the potential of biotechnology, from health research to the bioeconomy.
Delegates from Venture Valuation and Biotechgate will attend the event.
Read more